Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) [Phase 4]
This update reports the completion of a Phase 4 clinical trial evaluating the efficacy and safety of α-KA tablets with a low-protein diet to…
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: The Impact of Vitamins and Minerals Supplementation on Neuropathy and Nephropathy Complications [Phase 2]
Phase 2 trial evaluating the effect of vitamin and mineral supplementation on neuropathy and nephropathy in type 2 diabetes was completed.
-
CLINICAL_TRIALS other · 2010-06-02Clinical Trial Update: Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study [Phase 3]
Clinical trial update for a Phase 3 study of pancreas allotransplantation in type 1 diabetes patients with diabetic nephropathy and mild chr…
-
CLINICAL_TRIALS trial_result · 2010-05-27Clinical Trial Update: To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) [NA]
Clinical trial comparing Tripterygium wilfordii to valsartan in diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study [NA]
A completed clinical trial update from the University of Pittsburgh evaluating strategies to enhance adherence in type 2 diabetes, including…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. [Phase 2]
Phase 2 trial evaluating the effect of mycophenolate mofetil on anti-HLA antibodies in patients awaiting cadaveric renal transplant; results…
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant [Phase 2]
Phase 2 trial evaluating rituximab in combination with mycophenolate mofetil for highly sensitized patients awaiting kidney transplantation;…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Improving Outcomes in Patients With Kidney Disease Due to Diabetes [Phase 2]
A Phase 2 clinical trial investigating an intervention to improve outcomes in patients with diabetic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy [Phase 2]
A Phase 2 study evaluating XL784 in patients with albuminuria due to diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: Treatment of Diabetic Nephropathy [NA]
This clinical trial update notes the termination of an NIDDK-sponsored trial investigating treatments for diabetic nephropathy; no study res…
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Effect of Turmeric on Diabetic Nephropathy [NA]
Clinical trial investigating the effect of turmeric on diabetic nephropathy and proteinuria has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Benfotiamine in Diabetic Nephropathy [Phase 4]
This document reports the completion of a Phase 4 trial evaluating benfotiamine for diabetic nephropathy at the University Medical Center Gr…
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/2 testing of Pirfenidone for kidney disease in diabetes. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2009-10-30Clinical Trial Update: The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Sulodexide in Filipino patients with diabetes and chronic kidney disease; curre…
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program
This clinical trial update describes a study aiming to determine rates of cardiovascular complications among patients enrolled in a managed …
-
CLINICAL_TRIALS trial_result · 2009-10-01Clinical Trial Update: 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria [Phase 2]
Pfizer completed a 6-month Phase 2 study assessing the safety and efficacy of TTP488 in patients with type 2 diabetes and persistent albumin…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine? [Phase 4]
A Phase 4 trial examining how pioglitazone might reduce protein loss in urine in people with type 2 diabetes; the current status of the stud…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria [Phase 4]
Phase 4 trial update shows completion of irbesartan study in Chinese hypertensive diabetics with microalbuminuria; results may inform post-m…
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy [Phase 4]
Phase 4 trial update evaluating the safety of adding aliskiren to ACE inhibitors or ARBs in patients with Type 2 diabetes and nephropathy.
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy [NA]
This clinical trial update summarizes a completed study examining whether environmental lead exposure is linked to progressive renal insuffi…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria [Phase 4]
Phase 4 trial update assessing the effect of renin-angiotensin system blockade on Fas (CD95) and asymmetric dimethylarginine (ADMA) levels i…
-
FDA approval · 2009-05-29FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, enabling continued access to lisinopril…
-
CLINICAL_TRIALS trial_result · 2009-05-22Clinical Trial Update: The Use of Cilostazol in Patients With Diabetic Nephropathy [Phase 4]
Phase 4 trial update indicating completion of a study evaluating cilostazol in patients with diabetic nephropathy.
-
CLINICAL_TRIALS research · 2009-03-27Clinical Trial Update: Aldosterone in Diabetic Nephropathy [Phase 4]
Phase 4 clinical trial update on aldosterone in diabetic nephropathy conducted by Universidad de los Andes, Chile; current status is not dis…
-
CLINICAL_TRIALS research · 2009-02-19Clinical Trial Update: Shiga Progression of Diabetes, Nephropathy and Retinopathy [NA]
Clinical trial update focusing on progression of diabetes-related nephropathy and retinopathy in Type 2 diabetes mellitus.